Apr 18, 2026
President Trump signs executive order to expand federal research into psychedelics, including ibogaine, and directs $50 million investment
On April 18, 2026, President Donald Trump signed an executive order intended to ease federal research restrictions on psychedelic drugs, explicitly naming ibogaine a...